Muscular dystrophy (MD) is a disease characterized by accelerating skeletal muscle weakness, defects in muscle proteins (dystrophin concentration is extraordinarily diminished), and the death of muscle cells and tissue. Diagnosis is based on muscle biopsy, lab assessment (expanded levels of creatine phosphokinase) and EMG findings. There are nine major types of MD and most types of MD are multi-system disorders with manifestations in body systems including the heart, gastrointestinal system, nervous system, endocrine glands, eyes and brain. MD has a strong genetic link. Treatment choices are few. There has been a distinct interest in utilizing stem cells to regenerate muscle tissue and there has been success in utilizing human stem cells for MD in mice. There is hope that adipose derived stem cells may be adequate in regenerating muscle damaged by MD.
Muscular Dystrophy and Regenerative Medicine Institute of Nevada
The Regenerative Medicine Institute of Nevada has developed a particular SVF deployment convention that endeavors to use the potential regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is systemically deployed and is expected to hone to harmed areas specially. This is all done as an outpatient around the time of SVF collecting and obtainment. The whole cell surgical procedure takes roughly three hours.
Muscular Dystrophy Call to Action
In caring for our Muscular Dystrophy patients at the Regenerative Medicine Institute of Nevada, we take pride in using the best medical protocols and current technology to help our patients become their best. Contact us and we will answer the inquiries and concerns you might have about Regenerative Medicine Institute of Nevada conventions for Muscular Dystrophy.